Conference Report

Conference Report From the 2008 Gastrointestinal Cancers Symposium: Cancers of the Pancreas, Liver, and Hepatobiliary Tract

Source: CCO Independent Conference Coverage of the 2008 Gastrointestinal Cancers Symposium*

*CCO is an independent medical education company that provides state-of-the-art medical information to healthcare professionals through conference coverage and other educational programs.

Conference Report From the 2008 Gastrointestinal Cancers Symposium: Cancers of the Pancreas, Liver, and Hepatobiliary Tract


Faculty:

Jordan D. Berlin, MDBarbara Burtness, MD
  • Jordan D. Berlin, MD
  • Barbara Burtness, MD

CME CREDIT INFORMATION

Release Date: 04/01/08

Expiration Date: 03/31/09


Physicians: maximum of 0.75 AMA PRA Category 1 Credits™

Status: Please log in to view status

Begin the Conference Report

Learning Objectives

Upon completion of this activity, participants should be able to:

  • Recall recent clinical data regarding adjuvant chemoradiotherapy strategies in the setting of pancreatic cancer
  • Identify combinations of chemotherapies and biologics currently being evaluated for the treatment of pancreatic cancer
  • Discuss the use of sorafenib in patients with advanced hepatocellular carcinoma
  • Describe combinations of chemotherapies and biologics used to treat hepatocellular carcinoma

Topics covered include:

  • Overview
  • Gemcitabine Combinations in Advanced Pancreatic Cancer
  • Adjuvant Chemoradiotherapy for Patients With Pancreatic Cancer
  • Pancreatic Cancer: Genetic Clues to Risk and Treatment Response
  • New Data on Sorafenib in Hepatocellular Carcinoma
  • Combinations of Chemotherapies and Biologic Agents in Patients With Advanced HCC
  • Chemoradiotherapy for Patients With Cholangiocarcinoma
  • Vatalanib in Neuroendocrine Cancer
  • Survival in Patients With Pancreatic Endocrine Carcinomas
Disclaimer: The materials published on the Clinical Care Options Web site reflect the views of the reviewers or authors of the CCO material, not those of Clinical Care Options, LLC, the CME provider, or the companies providing educational grants. The materials may discuss uses and dosages for therapeutic products that have not been approved by the United States Food and Drug Administration. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or using any therapies described in these materials.

Jointly sponsored by Postgraduate Institute for Medicine and Clinical Care Options, LLC.

Contact Info

Educational grants provided by:

Educational grants support only the CME-certified components of this program.